Sven Krappmann

Dr. Sven Krappmann

Institute of Clinical Microbiology, Immunology and Hygiene, University Hospital Erlangen and Friedrich-Alexander University Erlangen-Nürnberg (FAU), Erlangen, Germany
orcid

Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 June 2008 in Science
Verified
Journal Article
Closed access
PDF file
OBÖzGür Bayram
ÖzGür Bayram
Sven KrappmannSven Krappmann
Sven Krappmann
MNMin Ni
Min Ni
JBJin Woo Bok
Jin Woo Bok
KHKerstin Helmstaedt
Kerstin Helmstaedt
GBGerhard H. Braus
Gerhard H. Braus
Differentiation and secondary metabolism are correlated processes in fungi that respond to light. In Aspergillus nidulans , light inhibits sexual reproduction as well as secondary metabolism. We identified the heterotrimeric velvet complex VelB/VeA/LaeA connecting light-responding developmental regulation and control of secondary metabolism. VeA, which is primarily expressed in the dark, physically interacts with VelB, which is expressed during sexual development. VeA bridges VelB to the nuclear master regulator of secondary metabolism, LaeA. Deletion of either velB or veA results in defects in both sexual fruiting-body formation and the production of secondary metabolites.

31 August 2016 in Fungal Biology and Biotechnology
Verified
Journal Article
Open access
PDF file
VMVera Meyer
Vera Meyer
MAMikael Rørdam Andersen
Mikael Rørdam Andersen
ABAxel Brakhage
Axel Brakhage
GBGerhard H. Braus
Gerhard H. Braus
MCMark X. Caddick
Mark X. Caddick
RHRitchie M. Head
Ritchie M. Head
The EUROFUNG network is a virtual centre of multidisciplinary expertise in the field of fungal biotechnology. The first academic-industry Think Tank was hosted by EUROFUNG to summarise the state of the art and future challenges in fungal biology and biotechnology in the coming decade. Currently, fungal cell factories are important for bulk manufacturing of organic acids, proteins, enzymes, secondary metabolites and active pharmaceutical ingredients in white and red biotechnology. In contrast, fungal pathogens of humans kill more people than malaria or tuberculosis. Fungi are significantly impacting on global food security, damaging global crop production, causing disease in domesticated animals, and spoiling an estimated 10 % of harvested crops. A number of challenges now need to be addressed to improve our strategies to control fungal pathogenicity and to optimise the use of fungi as sources for novel compounds and as cell factories for large scale manufacture of bio-based products. This white paper reports on the discussions of the Think Tank meeting and the suggestions made for moving fungal bio(techno)logy forward.

1 January 2006 in Eukaryotic Cell
Verified
Journal Article
Closed access
PDF file
Sven KrappmannSven Krappmann
Sven Krappmann
CSChristoph Sasse
Christoph Sasse
GBGerhard H. Braus
Gerhard H. Braus
The akuA gene encoding the Ku70 component of the nonhomologous end-joining machinery was deleted in the opportunistic pathogen Aspergillus fumigatus . No obvious phenotype could be assessed for the corresponding mutant strain but relative frequencies of homologous recombination were increased as deduced from targeting the laccase-encoding abr2 gene.

15 August 2016 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
MCMartin Chopra
Martin Chopra
MBMarlene Biehl
Marlene Biehl
TSTim Steinfatt
Tim Steinfatt
ABAndreas Brandl
Andreas Brandl
JKJuliane Kums
Juliane Kums
ABAndreas Beilhack
Andreas Beilhack
Donor CD4+Foxp3+ regulatory T cells (T reg cells) suppress graft-versus-host disease (GvHD) after allogeneic hematopoietic stem cell transplantation (HCT [allo-HCT]). Current clinical study protocols rely on the ex vivo expansion of donor T reg cells and their infusion in high numbers. In this study, we present a novel strategy for inhibiting GvHD that is based on the in vivo expansion of recipient T reg cells before allo-HCT, exploiting the crucial role of tumor necrosis factor receptor 2 (TNFR2) in T reg cell biology. Expanding radiation-resistant host T reg cells in recipient mice using a mouse TNFR2-selective agonist before allo-HCT significantly prolonged survival and reduced GvHD severity in a TNFR2- and T reg cell–dependent manner. The beneficial effects of transplanted T cells against leukemia cells and infectious pathogens remained unaffected. A corresponding human TNFR2-specific agonist expanded human T reg cells in vitro. These observations indicate the potential of our strategy to protect allo-HCT patients from acute GvHD by expanding T reg cells via selective TNFR2 activation in vivo.

1 August 2003 in Molecular Microbiology
Verified
Journal Article
Open access
PDF file
SBSilke Busch
Silke Busch
SESabine E. Eckert
Sabine E. Eckert
Sven KrappmannSven Krappmann
Sven Krappmann
GBGerhard H. Braus
Gerhard H. Braus
Summary: The COP9 signalosome (CSN) is a conserved multiprotein complex involved in regulation of eukaryotic development. The deduced amino acid sequences of two Aspergillus nidulans genes, csnD and csnE, show high identities to the fourth and fifth CSN subunits of higher eukaryotes. The csnD transcript is abundant during vegetative growth as well as development and the corresponding protein accumulates in the nucleus. Strains deleted for either csn gene are viable and show identical mutant phenotypes at conditions that allow development: hyphae appear partly red and contain cells of reduced size. Additionally, light dependence of propagation onset is affected. The Δcsn mutants are capable of initiating the sexual cycle and develop primordia, but maturation to sexual fruit bodies is blocked. This developmental arrest could not be overcome by overexpression of the sexual activator velvet (VEA). We conclude that the COP9 signalosome in A. nidulans is a key regulator of sexual development, and its proposed structural and functional conservation to the CSN of higher eukaryotes enables studies on this regulatory complex in a genetically amenable organism.

29 March 2004 in Molecular Microbiology
Verified
Journal Article
Open access
PDF file
Sven KrappmannSven Krappmann
Sven Krappmann
EBElaine M. Bignell
Elaine M. Bignell
URUtz Reichard
Utz Reichard
TRTom Rogers
Tom Rogers
KHKen Haynes
Ken Haynes
GBGerhard H. Braus
Gerhard H. Braus
Summary: We have cloned and characterized the Aspergillus fumigatus cpcA gene encoding the transcriptional activator of the cross‐pathway control system of amino acid biosynthesis. cpcA encodes a functional orthologue of Saccharomyces cerevisiae Gcn4p. The coding sequence of the 2.2 kb transcript is preceded by two short upstream open reading frames, the larger one being well conserved among Aspergilli. Deletion strains in which either the coding sequence or the entire locus are replaced by a bifunctional dominant marker are impaired in their cross‐pathway control response upon amino acid starvation, as demonstrated by analyses of selected reporter genes and specific enzymatic activities. In a murine model of pulmonary aspergillosis, cpcAΔ strains display attenuated virulence. Pathogenicity is restored to wild‐type levels in strains with reconstitution of the genomic locus. Competitive mixed infection experiments additionally demonstrate that cpcAΔ strains are less able to survive in vivo than their wild‐type progenitor. Our data suggest that specific stress conditions are encountered by A. fumigatus within the mammalian host and that the fungal cross‐pathway control system plays a significant role in pulmonary aspergillosis.